Page 54 - Read Online

Page 12 of 15 Friedman et al. Plast Aesthet Res 2023;10:23 https://dx.doi.org/10.20517/2347-9264.2022.100

up. Breast 2017;36:67-73. DOI PubMed
15. Montagna G, Zhang J, Sevilimedu V, et al. Risk factors and racial and ethnic disparities in patients with breast cancer-related
lymphedema. JAMA Oncol 2022;8:1195-200. DOI
16. Ahmad A. Breast Cancer Statistics: Recent Trends. In: Ahmad A, editor. Breast cancer metastasis and drug resistance. Cham:
Springer International Publishing; 2019. pp. 1-7. DOI
17. Schulze H, Nacke M, Gutenbrunner C, Hadamitzky C. Worldwide assessment of healthcare personnel dealing with lymphoedema.
Health Econ Rev 2018;8:10. DOI PubMed PMC
18. Duhon BH, Phan TT, Taylor SL, Crescenzi RL, Rutkowski JM. Current mechanistic understandings of lymphedema and lipedema:
tales of fluid, fat, and fibrosis. Int J Mol Sci 2022;23:6621. DOI PubMed PMC
19. Avraham T, Zampell JC, Yan A, et al. Th2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting
from lymphedema. FASEB J 2013;27:1114-26. DOI PubMed PMC
20. Savetsky IL, Ghanta S, Gardenier JC, et al. Th2 cytokines inhibit lymphangiogenesis. PLoS One 2015;10:e0126908. DOI PubMed
PMC
21. Ogata F, Fujiu K, Matsumoto S, et al. Excess lymphangiogenesis cooperatively induced by macrophages and CD4(+) T cells drives
the pathogenesis of lymphedema. J Invest Dermatol 2016;136:706-14. DOI
22. Baik JE, Park HJ, Kataru RP, et al. TGF-β1 mediates pathologic changes of secondary lymphedema by promoting fibrosis and
inflammation. Clin Transl Med 2022;12:e758. DOI
23. Hespe G, Nitti M, Mehrara B. Pathophysiology of lymphedema. Available from:
24. Aschen S, Zampell JC, Elhadad S, Weitman E, De Brot Andrade M, Mehrara BJ. Regulation of adipogenesis by lymphatic fluid
stasis: part II. expression of adipose differentiation genes. Plast Reconstr Surg 2012;129:838-47. DOI PubMed PMC
25. Miaskowski C, Dodd M, Paul SM, et al. Lymphatic and angiogenic candidate genes predict the development of secondary
lymphedema following breast cancer surgery. PLoS One 2013;8:e60164. DOI PubMed PMC
26. Finegold DN, Baty CJ, Knickelbein KZ, et al. Connexin 47 mutations increase risk for secondary lymphedema following breast
cancer treatment. Clin Cancer Res 2012;18:2382-90. DOI PubMed PMC
27. Finegold DN, Schacht V, Kimak MA, et al. HGF and MET mutations in primary and secondary lymphedema. Lymphat Res Biol
2008;6:65-8. DOI PubMed PMC
28. Rockson SG, Keeley V, Kilbreath S, Szuba A, Towers A. Cancer-associated secondary lymphoedema. Nat Rev Dis Primers
2019;5:22. DOI PubMed
29. Sudduth CL, Greene AK. Primary lymphedema: update on genetic basis and management. Adv Wound Care 2022;11:374-81. DOI
PubMed PMC
30. Ahmed RL, Schmitz KH, Prizment AE, Folsom AR. Risk factors for lymphedema in breast cancer survivors, the iowa women's
health study. Breast Cancer Res Treat 2011;130:981-91. DOI PubMed PMC
31. Tsai RJ, Dennis LK, Lynch CF, Snetselaar LG, Zamba GK, Scott-Conner C. The risk of developing arm lymphedema among breast
cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol 2009;16:1959-72. DOI PubMed
32. Yusof KM, Avery-Kiejda KA, Ahmad Suhaimi S, et al. Assessment of potential risk factors and skin ultrasound presentation
associated with breast cancer-related lymphedema in long-term breast cancer survivors. Diagnostics 2021;11:1303. DOI PubMed
PMC
33. Armer JM, Ballman KV, McCall L, et al. Factors associated with lymphedema in women with node-positive breast cancer treated
with neoadjuvant chemotherapy and axillary dissection. JAMA Surg 2019;154:800-9. DOI PubMed PMC
34. Ariel IM, Resnick MI, Oropeza R. The effects of irradiation (external and internal) on lymphatic dynamics. Am J Roentgenol Radium
Ther Nucl Med 1967;99:404-14. DOI PubMed
35. LENZI M, BASSANI G. The effect of radiation on the lymph and on the lymph vessels. Radiology 1963;80:814-7. DOI PubMed
36. Allam O, Park KE, Chandler L, et al. The impact of radiation on lymphedema: a review of the literature. Gland Surg 2020;9:596-602.
DOI PubMed PMC
37. Warren LE, Miller CL, Horick N, et al. The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer: a
prospective cohort study. Int J Radiat Oncol Biol Phys 2014;88:565-71. DOI PubMed PMC
38. Manirakiza A, Irakoze L, Shui L, Manirakiza S, Ngendahayo L. Lymphoedema after breast cancer treatment is associated with higher
body mass index: a systematic review and meta-analysis. East Afr Health Res J 2019;3:178-92. DOI PubMed PMC
39. Wu R, Huang X, Dong X, Zhang H, Zhuang L. Obese patients have higher risk of breast cancer-related lymphedema than overweight
patients after breast cancer: a meta-analysis. Ann Transl Med 2019;7:172. DOI PubMed PMC
40. Ridner SH, Dietrich MS, Stewart BR, Armer JM. Body mass index and breast cancer treatment-related lymphedema. Support Care
Cancer 2011;19:853-7. DOI PubMed PMC
41. Mehrara BJ, Greene AK. Lymphedema and obesity: is there a link? Plast Reconstr Surg 2014;134:154e-60e. DOI PubMed PMC
42. Zhu W, Li D, Li X, et al. Association between adjuvant docetaxel-based chemotherapy and breast cancer-related lymphedema.
Anticancer Drugs 2017;28:350-5. DOI
43. Hugenholtz-Wamsteker W, Robbeson C, Nijs J, Hoelen W, Meeus M. The effect of docetaxel on developing oedema in patients with
breast cancer: a systematic review. Eur J Cancer Care 2016;25:269-79. DOI PubMed
44. Kim M, Kim SW, Lee SU, et al. A model to estimate the risk of breast cancer-related lymphedema: combinations of treatment-related
factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy. Int J Radiat Oncol Biol Phys